---
abstract: Castration-resistant prostate cancer CRPC represents a therapeutic challenge
  for current medications.
authors: Vainio P, Wolf M, Edgren H, He T, Kohonen P, Mpindi JP, Smit F, Verhaegh
  G, Schalken J, Perala M, Iljin K and Kallioniemi O.
cancertypes: []
contact:
  email: olli.kallioniemi@helsinki.fi
  name: Olli Kallioniemi
counts:
  biosamples: 18
  samples_acgh: 18
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:21919029
- geo:GSE28403
geo_data:
  geo_json:
    coordinates:
    - 22.27
    - 60.45
    type: Point
  info:
    city: Turku
    continent: Europe
    country: Finland
    label: Turku, Finland, Europe
    precision: city
journal: Prostate (2011)
label: 'Vainio et al. (2011): Integrative Genomic, Transcriptomic, and Rnai Analysis
  Indicates a Potential Oncogenic Role for ...'
notes: ~
pmid: 21919029
title: Integrative Genomic, Transcriptomic, and Rnai Analysis Indicates a Potential
  Oncogenic Role for Fam110B in Castration-Resistant Prostate Cancer.
year: 2011
